Obesity-related immune responses and their impact on surgical outcomes

International Journal of Obesity

Volumn 39, Issue 6, 2015, Pages 877-883

  Quante, M ^a,b,c   Dietrich, A ^b,c   Elkhal, A ^a   Tullius, S G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; AUTACOID; BIOLOGICAL MARKER;

ADIPOSE TISSUE; ALLOIMMUNITY; BARIATRIC SURGERY; CLINICAL TRIAL (TOPIC); GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; INFLAMMATORY DISEASE; NONHUMAN; NUTRITION; OBESITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW (TOPIC); ADVERSE EFFECTS; COMPLICATION; CONTRAINDICATIONS; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE; METABOLISM; POSTOPERATIVE COMPLICATION; RISK FACTOR; SURGERY; TREATMENT OUTCOME; UNITED STATES;

BIOMARKERS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LYMPHOCYTES; OBESITY; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; UNITED STATES;

EID: 84930759395     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.21     Document Type: Review

References (94)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497.
2. Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009; 250: 166-172.
3. Cannon RM, Jones CM, Hughes MG, Eng M, Marvin MR. The impact of recipient obesity on outcomes after renal transplantation. Ann Surg 2013; 257: 978-984.
4. Khwaja A, El-Nahas M. Transplantation in the obese: separating myth from reality. Nephrol Dial Transplant 2012; 27: 3732-3735.
5. Tobias DK, Pan A, Jackson CL, O'Reilly EJ, Ding EL, Willett WC et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med 2014; 370: 233-244.
6. Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 2011; 11: 738-749.
7. Kanneganti TD, Dixit VD. Immunological complications of obesity. Nat Immunol 2012; 13: 707-712.
8. House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 2008; 12: 270-278.
9. Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol 2008; 15: 2164-2172.
10. Giles KA, Wyers MC, Pomposelli FB, Hamdan AD, Ching YA, Schermerhorn ML. The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the National Surgical Quality Improvement Program, 2005-2007. J Vasc Surg 2010; 52: 1471-1477.
11. Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet 2003; 361: 2032-2035.
12. Glance LG, Li Y, Osler TM, Mukamel DB, Dick AW. Impact of obesity on mortality and complications in trauma patients. Ann Surg 2014; 259: 576-581.
13. Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K et al. Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinoma. Hepatogastroenterology 2004; 51: 1225-1228.
14. Pata G, Solaini L, Roncali S, Pasini M, Ragni F. Impact of obesity on early surgical and oncologic outcomes after total gastrectomy with "over-D1" lymphadenectomy for gastric cancer. World J Surg 2013; 37: 1072-1081.
15. Blee TH, Belzer GE, Lambert PJ. Obesity: is there an increase in perioperative complications in those undergoing elective colon and rectal resection for carcinoma? Am Surg 2002; 68: 163-166.
16. Bamgbade OA, Rutter TW, Nafiu OO, Dorje P. Postoperative complications in obese and nonobese patients. World J Surg 2007; 31: 556-560 discussion 561.
17. Dossett LA, Dageforde LA, Swenson BR, Metzger R, Bonatti H, Sawyer RG et al. Obesity and site-specific nosocomial infection risk in the intensive care unit. Surg Infect (Larchmt) 2009; 10: 137-142.
18. Bailey MB, Davenport DL, Procter L, McKenzie S, Vargas HD. Morbid obesity and diverticulitis: results from the ACS NSQIP dataset. J Am Coll Surg 2013; 217: 874-880 e1.
19. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 2012; 36: 1072-1077.
20. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013; 347: f5061.
21. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc 2012; 71: 298-306.
22. O'Shea D, Corrigan M, Dunne MR, Jackson R, Woods C, Gaoatswe G et al. Changes in human dendritic cell number and function in severe obesity may contribute to increased susceptibility to viral infection. Int J Obes (Lond) 2013; 37: 1510-1513.
23. Newsholme P, Gaudel C, Krause M. Mitochondria and diabetes. An intriguing pathogenetic role. Adv Exp Med Biol 2012; 942: 235-247.
24. Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol 2013; 9: 674-686.
25. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
26. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132: 2169-2180.
27. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184.
28. Odegaard JI, Chawla A. Alternative macrophage activation and metabolism. Annu Rev Pathol 2011; 6: 275-297.
29. Liu X, Ntambi JM. Atherosclerosis: keep your macrophages in shape. Nat Med 2009; 15: 1357-1358.
30. Ohmura K, Ishimori N, Ohmura Y, Tokuhara S, Nozawa A, Horii S et al. Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler Thromb Vasc Biol 2010; 30: 193-199.
31. Johnson AR, Milner JJ, Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 2012; 249: 218-238.
32. Konner AC, Bruning JC. Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab 2011; 22: 16-23.
33. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783.
34. Gainsford T, Willson TA, Metcalf D, Handman E, McFarlane C, Ng A et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 1996; 93: 14564-14568.
35. Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001; 166: 5909-5916.
36. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897-901.
37. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004; 323: 630-635.
38. Matarese G, Procaccini C, De Rosa V. At the crossroad of T cells, adipose tissue, and diabetes. Immunol Rev 2012; 249: 116-134.
39. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347: f5934.
40. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-256 e5.
41. Brethauer SA, Aminian A, Romero-Talamas H, Batayyah E, Mackey J, Kennedy L et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg 2013; 258: 628-636 discussion 636-7.
42. Sjostrom L. Review of the key results from the Swedish obese subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273: 219-234.
43. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240: 416-423 discussion 423-424.
44. Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 2011; 253: 484-487.
45. Chen M, Krishnamurthy A, Mohamed AR, Green R. Hematological disorders following gastric bypass surgery: emerging concepts of the interplay between nutritional deficiency and inflammation. Biomed Res Int 2013; 2013: 205467.
46. Bradley D, Conte C, Mittendorfer B, Eagon JC, Varela JE, Fabbrini E et al. Gastric bypass and banding equally improve insulin sensitivity and beta cell function. J Clin Invest 2012; 122: 4667-4674.
47. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54: 2277-2286.
48. Illan-Gomez F, Gonzalvez-Ortega M, Orea-Soler I, Alcaraz-Tafalla MS, Aragon-Alonso A, Pascual-Diaz M et al. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg 2012; 22: 950-955.
49. Goktas Z, Moustaid-Moussa N, Shen CL, Boylan M, Mo H, Wang S. Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol (Lausanne) 2013; 4: 69.
50. Siejka A, Jankiewicz-Wika J, Kolomecki K, Cywinski J, Piestrzeniewicz K, Swietoslawski J et al. Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity. Cytokine 2013; 64: 490-493.
51. Terra X, Auguet T, Guiu-Jurado E, Berlanga A, Orellana-Gavalda JM, Hernandez M et al. Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg 2013; 23: 1790-1798.
52. Cigdem Arica P, Kocael A, Tabak O, Taskin M, Zengin K, Uzun H. Plasma ghrelin, leptin, and orexin-A levels and insulin resistance after laparoscopic gastric band applications in morbidly obese patients. Minerva Med 2013; 104: 309-316.
53. Geloneze B, Geloneze SR, Chaim E, Hirsch FF, Felici AC, Lambert G et al. Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Ann Surg 2012; 256: 72-78.
54. Jacobsen SH, Olesen SC, Dirksen C, Jorgensen NB, Bojsen-Moller KN, Kielgast U et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg 2012; 22: 1084-1096.
55. Huang CJ, Zourdos MC, Jo E, Ormsbee MJ. Influence of physical activity and nutrition on obesity-related immune function. Sci World J 2013; 2013: 752071.
56. DiPenta JM, Johnson JG, Murphy RJ. Natural killer cells and exercise training in the elderly: a review. Can J Appl Physiol 2004; 29: 419-443.
57. Spector D, Shikora S. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus. Int J Clin Pract Suppl 2010; : 53-58.
58. Hosseinzadeh-Attar MJ, Golpaie A, Janani L, Derakhshanian H. Effect of weight reduction following bariatric surgery on serum visfatin and adiponectin levels in morbidly obese subjects. Obes Facts 2013; 6: 193-202.
59. Bachmayer C, Lammert A, Hasenberg T, Hammes HP. Healthy obese and post bariatric patients - metabolic and vascular patterns. Exp Clin Endocrinol Diabetes 2013; 121: 483-487.
60. Auguet T, Terra X, Hernandez M, Sabench F, Porras JA, Orellana-Gavalda JM et al. Clinical and adipocytokine changes after bariatric surgery in morbidly obese women. Obesity (Silver Spring) 2014; 22: 188-194.
61. Hirsch FF, Pareja JC, Geloneze SR, Chaim E, Cazzo E, Geloneze B. Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-term remission versus non-remission of type 2 diabetes. Obes Surg 2012; 22: 910-917.
62. Heinbokel T, Floerchinger B, Schmiderer A, Edtinger K, Liu G, Elkhal A et al. Obesity and its impact on transplantation and alloimmunity. Transplantation 2013; 96: 10-16.
63. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827.
64. Pham PT, Danovitch GM, Pham PC. Kidney transplantation in the obese transplant candidates: to transplant or not to transplant? Semin Dial 2013; 26: 568-577.
65. Moraes-Vieira PM, Bassi EJ, Larocca RA, Castoldi A, Burghos M, Lepique AP et al. Leptin modulates allograft survival by favoring a Th2 and a regulatory immune profile. Am J Transplant 2013; 13: 36-44.
66. Okamoto Y, Christen T, Shimizu K, Asano K, Kihara S, Mitchell RN et al. Adiponectin inhibits allograft rejection in murine cardiac transplantation. Transplantation 2009; 88: 879-883.
67. Modanlou KA, Muthyala U, Xiao H, Schnitzler MA, Salvalaggio PR, Brennan DC et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation 2009; 87: 1167-1173.
68. Lin MY, Tavakol MM, Sarin A, Amirkiai SM, Rogers SJ, Carter JT et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis 2013; 9: 653-658.
69. Szomstein S, Rojas R, Rosenthal RJ. Outcomes of laparoscopic bariatric surgery after renal transplant. Obes Surg 2010; 20: 383-385.
70. Ahmed MH, Byrne CD. Bariatric surgery and renal function: a precarious balance between benefit and harm. Nephrol Dial Transplant 2010; 25: 3142-3147.
71. Chen T, Godebu E, Horgan S, Mirheydar HS, Sur RL. The effect of restrictive bariatric surgery on urolithiasis. J Endourol 2013; 27: 242-244.
72. Tariq N, Moore LW, Sherman V. Bariatric surgery and end-stage organ failure. Surg Clin North Am 2013; 93: 1359-1371.
73. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996; 143: 228-239.
74. Kartheuser AH, Leonard DF, Penninckx F, Paterson HM, Brandt D, Remue C et al. Waist circumference and waist/hip ratio are better predictive risk factors for mortality and morbidity after colorectal surgery than body mass index and body surface area. Ann Surg 2013; 258: 722-730.
75. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649.
76. Streja E, Molnar MZ, Kovesdy CP, Bunnapradist S, Jing J, Nissenson AR et al. Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol 2011; 6: 1463-1473.
77. Lugli AK, Wykes L, Carli F. Strategies for perioperative nutrition support in obese, diabetic and geriatric patients. Clin Nutr 2008; 27: 16-24.
78. Jeevanandam M, Young DH, Schiller WR. Obesity and the metabolic response to severe multiple trauma in man. J Clin Invest 1991; 87: 262-269.
79. Lee H, Lee IS, Choue R. Obesity, inflammation and diet. Pediatr Gastroenterol Hepatol Nutr 2013; 16: 143-152.
80. Choban P, Dickerson R, Malone A, Worthington P, Compher C. ASPEN Clinical guidelines: nutrition support of hospitalized adult patients with obesity. J Parenter Enteral Nutr 2013; 37: 714-744.
81. O'Rourke RW. Inflammation, obesity, and the promise of immunotherapy for metabolic disease. Surg Obes Relat Dis 2013; 9: 609-616.
82. Dominguez H, Storgaard H, Rask-Madsen C, Steffen Hermann T, Ihlemann N, Baunbjerg Nielsen D et al. Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes. J Vasc Res 2005; 42: 517-525.
83. Ursini F, Naty S, Grembiale RD. Infliximab and insulin resistance. Autoimmun Rev 2010; 9: 536-539.
84. Gupta-Ganguli M, Cox K, Means B, Gerling I, Solomon SS. Does therapy with anti-TNF-alpha improve glucose tolerance and control in patients with type 2 diabetes? Diabetes Care 2011; 34: e121.
85. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356: 1517-1526.
86. Akash MS, Shen Q, Rehman K, Chen S. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci 2012; 101: 1647-1658.
87. Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY, Mandrup-Poulsen T. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 2009; 32: 1663-1668.
88. Benoist S, Panis Y, Alves A, Valleur P. Impact of obesity on surgical outcomes after colorectal resection. Am J Surg 2000; 179: 275-281.
89. Mathur AK, Ghaferi AA, Osborne NH, Pawlik TM, Campbell DA, Englesbe MJ et al. Body mass index and adverse perioperative outcomes following hepatic resection. J Gastrointest Surg 2010; 14: 1285-1291.
90. Klasen J, Junger A, Hartmann B, Jost A, Benson M, Virabjan T et al. Increased body mass index and peri-operative risk in patients undergoing non-cardiac surgery. Obes Surg 2004; 14: 275-281.
91. Jeschke MG, Finnerty CC, Emdad F, Rivero HG, Kraft R, Williams Fn et al. Mild obesity is protective after severe burn injury. Ann Surg 2013; 258: 1119-1129.
92. Davenport DL, Xenos ES, Hosokawa P, Radford J, Henderson WG, Endean ED. The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 2009; 49: 140-147, e1; discussion 147.
93. Valentijn TM, Galal W, Hoeks SE, van Gestel YR. Verhagen HJ, Stolker RJ. Impact of obesity on postoperative and long-term outcomes in a general surgery population: a Retrospective Cohort Study. World J Surg 2013; 37: 2561-2568.
94. Orci LA, Majno PE, Berney T, Morel P. Mentha G, Toso C. The impact of wait list body mass index changes on the outcome after liver transplantation. Transpl Int 2013; 26: 170-176.